In a previous post, we described an April 2019 Citizen Petition filed by Braeburn Pharmaceuticals asking the Food and Drug Administration (FDA) to revoke orphan drug designation and refuse to grant ...

Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

The Drug Enforcement Administration’s approach to buprenorphine regulation is exacerbating the opioid epidemic by unnecessarily discouraging pharmacies from dispensing the drug, pharmacists and harm ...

Suboxone (buprenorphine/naloxone) is a prescription oral film that’s used in adults to treat dependence on opioid drugs. There are risks and benefits to consider before taking Suboxone during ...

First responders in Minnesota’s capital city will have increased access to a tool to fight opioid addiction. St. Paul interim ...

With a $385 million settlement, Suboxone maker Indivior is moving to wrap up years of antitrust litigation tied to its opioid addiction treatment. The company will shell out the money to resolve ...

Buprenorphine is a prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat opioid dependence in adults. Opioid dependence is also called opioid use disorder (OUD), ...

WASHINGTON — In a potential paradigm shift for addiction medicine, New Jersey’s health commissioner this week authorized paramedics to administer the drug buprenorphine to patients almost immediately ...

Buprenorphine sublingual tablet is a generic prescription drug that’s used to help treat opioid dependence (also known as opioid use disorder). The buprenorphine tablet does not come in a brand-name ...